Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2022

09.09.2021 | Original Article

Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case–Control Study

verfasst von: Ashish Chauhan, Prasenjit Das, Alka Singh, Rimlee Dutta, Madhu Rajeshwari, Mahendra Singh Rajput, Ashish Agarwal, Vikas Banyal, Ashish Upadhay, Vineet Ahuja, Govind Makharia

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

While celiac disease (CeD) is considered to affect primarily the small intestine, pathological changes in other parts of the gastrointestinal tract (GIT) are also known to occur. IgA anti-tissue transglutaminase-2 antibody (anti-TG2 Ab) deposits at the site of involvement is one of the methods to establish CeD-related tissue pathology.

Aims

To explore the utility of IgA anti-TG2 Ab deposits in pan-gastrointestinal mucosal biopsies as evidence of CeD-related pathologies.

Methods

Forty-two treatment-naive patients with CeD and 45 patients with irritable bowel syndrome were included as cases and controls, respectively. Mucosal biopsies were collected from the esophagus, stomach, duodenum, and rectosigmoid regions at baseline from cases and controls, and additionally after 6-months of gluten-free diet in cases. All biopsies were evaluated for histological changes and subjected to dual-color immunohistochemical staining for identifying IgA anti-TG2 Ab deposits.

Results

Significantly higher number of patients with CeD had lymphocytic esophagitis (9.7% vs. 0%, P = 0.05), lymphocytic gastritis (35% vs. 8.8%, P < 0.01) and lymphocytic colitis (17.4% vs. 0%, P < 0.05) than that in controls. IgA anti-TG2 Ab deposits were observed in significantly more numbers in esophagus (30.9% vs. 6%, P < 0.001), stomach (62.2% vs. 9.3%, P < 0.01), duodenum (88.5% vs. 0%, P < 0.001) and rectum (17.4% vs. 0%, P < 0.05) than that in controls. There was a decline, but not statistically significant, in severity of lymphocytosis and intensity of IgA anti-TG2 Ab deposits in follow-up biopsies.

Conclusion

Significantly higher number of patients with CeD had evidence of lymphocytic infiltration and IgA anti-TG2 deposits along GIT suggesting that CeD affects other parts of GIT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ludvigsson JF, Leffler DA, Bai JC et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43.CrossRef Ludvigsson JF, Leffler DA, Bai JC et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43.CrossRef
2.
Zurück zum Zitat Green PHR, Cellier C. Celiac disease. N Engl J Med 2007;357:1731–1743.CrossRef Green PHR, Cellier C. Celiac disease. N Engl J Med 2007;357:1731–1743.CrossRef
3.
Zurück zum Zitat Singh P, Arora A, Strand TA et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:823-836.e2.CrossRef Singh P, Arora A, Strand TA et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:823-836.e2.CrossRef
4.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabó IR et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–160.CrossRef Husby S, Koletzko S, Korponay-Szabó IR et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–160.CrossRef
6.
Zurück zum Zitat Dutta R, Iqbal A, Das P et al. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques. J Clin Pathol 2021;2020:206735. Dutta R, Iqbal A, Das P et al. Liver involvement in patients with coeliac disease: proof of causality using IgA/anti-TG2 colocalisation techniques. J Clin Pathol 2021;2020:206735.
7.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabó I et al. European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease. J Pediatr Gastroenterol Nutr 2020;70:141–156.CrossRef Husby S, Koletzko S, Korponay-Szabó I et al. European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease. J Pediatr Gastroenterol Nutr 2020;70:141–156.CrossRef
8.
Zurück zum Zitat Lacy BE, Mearin F, Chang L et al. Bowel disorders. Gastroenterology 2016;150:1393-1407.e5.CrossRef Lacy BE, Mearin F, Chang L et al. Bowel disorders. Gastroenterology 2016;150:1393-1407.e5.CrossRef
9.
Zurück zum Zitat Husby S, Koletzko S, Korponay-Szabo IR et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–160.CrossRef Husby S, Koletzko S, Korponay-Szabo IR et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136–160.CrossRef
10.
Zurück zum Zitat Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol J Can Gastroenterol 2001;15:591–598.CrossRef Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol J Can Gastroenterol 2001;15:591–598.CrossRef
11.
Zurück zum Zitat Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005;36:228–233.CrossRef Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005;36:228–233.CrossRef
12.
Zurück zum Zitat Magro F, Langner C, Driessen A et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013;7:827–851.CrossRef Magro F, Langner C, Driessen A et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013;7:827–851.CrossRef
13.
Zurück zum Zitat Fiocca R, Mastracci L, Riddell R et al. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol 2010;41:223–231.CrossRef Fiocca R, Mastracci L, Riddell R et al. Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol 2010;41:223–231.CrossRef
14.
Zurück zum Zitat Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185.CrossRef Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185.CrossRef
15.
Zurück zum Zitat Lucendo AJ, Molina-Infante J, Arias Á et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur Gastroenterol J 2017;5:335–358.CrossRef Lucendo AJ, Molina-Infante J, Arias Á et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur Gastroenterol J 2017;5:335–358.CrossRef
16.
Zurück zum Zitat Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterology (2013) ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 108:679–692; quiz 693 Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterology (2013) ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 108:679–692; quiz 693
17.
Zurück zum Zitat Baruah B, Kumar T, Das P et al. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: A cross-sectional study from a tertiary care hospital in North India. Indian J Gastroenterol 2017;36:353–360.CrossRef Baruah B, Kumar T, Das P et al. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: A cross-sectional study from a tertiary care hospital in North India. Indian J Gastroenterol 2017;36:353–360.CrossRef
18.
Zurück zum Zitat Rubio CA, Sjödahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol 2006;125:432–437.CrossRef Rubio CA, Sjödahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol 2006;125:432–437.CrossRef
19.
Zurück zum Zitat Rugge M, Correa P, Dixon MF et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading: classification of gastric mucosal atrophy. Aliment Pharmacol Ther 2002;16:1249–1259.CrossRef Rugge M, Correa P, Dixon MF et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading: classification of gastric mucosal atrophy. Aliment Pharmacol Ther 2002;16:1249–1259.CrossRef
20.
Zurück zum Zitat Collins MH, Capocelli K, Yang G-Y. Eosinophilic gastrointestinal disorders pathology. Front Med 2018;4:261.CrossRef Collins MH, Capocelli K, Yang G-Y. Eosinophilic gastrointestinal disorders pathology. Front Med 2018;4:261.CrossRef
21.
Zurück zum Zitat Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011;140:1155–1165.CrossRef Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011;140:1155–1165.CrossRef
22.
Zurück zum Zitat Mullhaupt B, Güller U, Anabitarte M, Güller R, Fried M. Lymphocytic colitis: clinical presentation and long term course. Gut 1998;43:629.CrossRef Mullhaupt B, Güller U, Anabitarte M, Güller R, Fried M. Lymphocytic colitis: clinical presentation and long term course. Gut 1998;43:629.CrossRef
23.
Zurück zum Zitat Bates AWH. Diagnosing Eosinophilic Colitis: histopathological pattern or nosological entity? Scientifica 2012;2012:1–9.CrossRef Bates AWH. Diagnosing Eosinophilic Colitis: histopathological pattern or nosological entity? Scientifica 2012;2012:1–9.CrossRef
24.
Zurück zum Zitat Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic EsophagitisA chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol 2008;130:508–513.CrossRef Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic EsophagitisA chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol 2008;130:508–513.CrossRef
25.
Zurück zum Zitat Feeley KM, Heneghan MA, Stevens FM, McCarthy CF. Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol 1998;51:207–210.CrossRef Feeley KM, Heneghan MA, Stevens FM, McCarthy CF. Lymphocytic gastritis and coeliac disease: evidence of a positive association. J Clin Pathol 1998;51:207–210.CrossRef
26.
Zurück zum Zitat Prasad KK, Thapa BR, Lal S, Sharma AK, Nain CK, Singh K. Lymphocytic gastritis and celiac disease in Indian children: evidence of a positive relation. J Pediatr Gastroenterol Nutr 2008;47:568–572.CrossRef Prasad KK, Thapa BR, Lal S, Sharma AK, Nain CK, Singh K. Lymphocytic gastritis and celiac disease in Indian children: evidence of a positive relation. J Pediatr Gastroenterol Nutr 2008;47:568–572.CrossRef
27.
Zurück zum Zitat Fine KD, Lee EL, Meyer RL. Colonic histopathology in untreated celiac sprue or refractory sprue: is it lymphocytic colitis or colonic lymphocytosis? Hum Pathol 1998;29:1433–1440.CrossRef Fine KD, Lee EL, Meyer RL. Colonic histopathology in untreated celiac sprue or refractory sprue: is it lymphocytic colitis or colonic lymphocytosis? Hum Pathol 1998;29:1433–1440.CrossRef
28.
Zurück zum Zitat Kaukinen K, Peräaho M, Collin P et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005;40:564–572.CrossRef Kaukinen K, Peräaho M, Collin P et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005;40:564–572.CrossRef
29.
Zurück zum Zitat Borrelli M, Maglio M, Korponay-Szabó IR et al. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study. Clin Exp Immunol 2018;191:311–317.CrossRef Borrelli M, Maglio M, Korponay-Szabó IR et al. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study. Clin Exp Immunol 2018;191:311–317.CrossRef
30.
Zurück zum Zitat Meresse B, Chen Z, Ciszewski C et al. Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease. Immunity 2004;21:357–366.CrossRef Meresse B, Chen Z, Ciszewski C et al. Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease. Immunity 2004;21:357–366.CrossRef
31.
Zurück zum Zitat Lundqvist C, Melgar S, Yeung MM, Hammarström S. Hammarström ML (1996) Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol Baltim Md 1950;157:1926–1934. Lundqvist C, Melgar S, Yeung MM, Hammarström S. Hammarström ML (1996) Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions. J Immunol Baltim Md 1950;157:1926–1934.
32.
Zurück zum Zitat Sollid LM. Intraepithelial Lymphocytes in Celiac Disease. Immunity 2004;21:303–304.PubMed Sollid LM. Intraepithelial Lymphocytes in Celiac Disease. Immunity 2004;21:303–304.PubMed
33.
Zurück zum Zitat Mayassi T, Jabri B. Human intraepithelial lymphocytes. Mucosal Immunol 2018;11:1281–1289.CrossRef Mayassi T, Jabri B. Human intraepithelial lymphocytes. Mucosal Immunol 2018;11:1281–1289.CrossRef
34.
Zurück zum Zitat Catassi C, Alaedini A, Bojarski C et al. The overlapping area of non-celiac gluten sensitivity (NCGS) and wheat-sensitive irritable bowel syndrome (IBS): an update. Nutrients 2017;9:E1268.CrossRef Catassi C, Alaedini A, Bojarski C et al. The overlapping area of non-celiac gluten sensitivity (NCGS) and wheat-sensitive irritable bowel syndrome (IBS): an update. Nutrients 2017;9:E1268.CrossRef
Metadaten
Titel
Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case–Control Study
verfasst von
Ashish Chauhan
Prasenjit Das
Alka Singh
Rimlee Dutta
Madhu Rajeshwari
Mahendra Singh Rajput
Ashish Agarwal
Vikas Banyal
Ashish Upadhay
Vineet Ahuja
Govind Makharia
Publikationsdatum
09.09.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07246-1

Weitere Artikel der Ausgabe 8/2022

Digestive Diseases and Sciences 8/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.